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The concentration of porcine interleukin-l/I (pILlB) required to elicit half-maximal IL2 production from 
NOB-l, a subline of murine thymoma EL4, was lOO-fold greater than for plLcc. In contrast, similar doses 
of each type of IL1 stimulated increased lactate production by Balb/C 3T3 fibroblasts. Receptor-bound 1251- 
ILlrr was displaced with equal efficiency by both unlabelled forms from 3T3 cells, but a 20-fold lower affinity 
for plLl/? was observed using NOB-l. Crosslinking experiments suggested that the IL1 receptors on each 
line consisted of two polypeptides of 80 and 100 kDa. The results provide the first evidence for a multiple- 
component IL1 receptor within which ILlc( and ILla may bind at different loci, and suggest the receptors 
may have evolved differently in the two lines. 
Interleukin-1 receptor; Interleukin-1; (Mouse thymoma cell; 3T3 fibroblast) 
1. INTRODUCTION 
Interleukin-1 (ILl) is the name given to a family 
of polypeptides produced by activated monocytes 
and macrophages which share multiple biological 
activities [l]. Originally defined as a lymphocyte- 
activating factor [2], IL1 also acts as a local hor- 
mone, mediating many of the effects of inflamma- 
tion and regulating local tissue remodelling [3]. 
There are at least two forms of ILl, called a and 
/?, which although sharing only limited homology, 
interact with a common receptor on all cell types 
studied to date [4-71. 
human ILl,& to murine 3T3 fibroblasts and 
LBRM-33-lA5 T lymphoma cells it was concluded 
that the molecular sizes of the receptors and their 
binding affinities were broadly similar. 
Here, we have exploited the differential 
responses of a murine fibroblast line and a T-cell 
line to natural porcine ILla and IL&& in order to 
demonstrate differences in the ILl-binding 
characteristics of the two cell types. For ex- 
periments designed to reveal possible structural 
differences in IL1 receptors of the two cell types we 
used a novel crosslinking procedure which revealed 
a previously unreported ILl-receptor polypeptide. 
A crucial question concerns the similarity be- 
tween IL1 receptors on cells of different lineages. 
In a recent study [5] of the binding of recombinant 2. MATERIALS AND METHODS 
2.1. Cell cultures 
Correspondence address: T.A. Bird, Cytokine Balb/C 3T3 fibroblasts (clone A31) were 
Biochemistry Group, Strangeways Research cultured in Dulbecco’s modified medium contain- 
Laboratory, Worts’ Causeway, Cambridge CBl 4RN, ing 10% foetal calf serum (FCS). The NOB-l 
England subline of EL4-6.1 thymoma [S] was cultured in 
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RPM1 1640 containing 5% FCS. All cultures were 
maintained at 37°C in a humidified atmosphere of 
air enriched with 5% COZ. 
2.2. Reagents 
ILla and p were purified from culture super- 
natants of concanavalin A-stimulated porcine buf- 
fy coat leucocytes [9]. pILl,& was radioiodinated 
with Bolton-Hunter reagent to around 
500 Ci/mmol exactly as in [4]; pILlcv was labelled 
using a modified chloramine-T procedure [lo] to 
1800 Ci/mmol. Both preparations migrated as 
single bands of 21 kDa upon SDS-PAGE and were 
fully active in a cartilage resorption assay [9]. 
Recombinant murine IL1 was a gift from Dr P. 
Lomedico (Hoffmann-La Roche, Nutley, NJ). The 
covalent crosslinking reagents ethylene glycol 
bis(succinimidy1 succinate) (EGS) and sulfosuc- 
cinimidyl 6-(4’-azido-2’-nitrophenylamino)hex- 
anoate (SS) were from Pierce (Pierce & Warriner, 
Chester, England). 
2.3. Biological assays 
The two-stage assay for IL1 using NOB-l has 
been fully described elsewhere [8]. Very briefly, 
washed NOB-l cells (2 x 105) were incubated with 
IL1 samples in 200~1 RPM1 1640 containing 5% 
FCS. After 24 h, aliquots of the medium were 
transferred to microtitration wells containing the 
IL2-responsive cytotoxic mouse T-cell line CTLL 
(4 x lo3 cells/well). 18 h later, proliferation was 
measured by pulsing the cells for 3 h with 0.5 &i 
[3H]thymidine per well. For measurement of 
glycolysis, newly confluent monolayers of 3T3 
fibroblasts (2 x 10’ cells/well) were washed in two 
changes of maintenance medium and incubated for 
48 h in 0.5 ml of fresh medium containing IL1 
samples. Following deproteinization of the super- 
natants using perchloric acid, their lactate content 
was measured by the lactate dehydrogenase 
method using a kit supplied by Sigma (St. Louis, 
MO). 
2.4. Binding assays 
3T3 cells were seeded into 25-well plates at 2 x 
lo4 cells/well and used 4-5 days later when con- 
fluent. The monolayers were washed twice with 
binding buffer [Hank’s balanced salts sup- 
plemented with 20 mM Hepes and O.lolo (w/v) 
BSA] and incubated, with gentle shaking, for 4 h 
at 12°C in 0.4 ml of fresh binding buffer contain- 
ing labelled and unlabelled ligands as required. 
The plates were then rinsed rapidly with three 
changes of ice-cold binding buffer, and bound 
radioactivity was counted following solubilization 
of the cell layers in 1 olo SDS/O. 1 N NaOH. NOB-l 
Log IL-1 CONCENTRATION (Ml 
Fig.1. Comparison of the concentration dependence of pig ILlcv and ILlp activity in 3T3 cells and NOB-l cells. (A) 
Lactate production was measured in Balb/C 3T3 fibroblasts a  described in the text; triplicate wells were incubated for 
48 h with pILla (0) or fl (0). (B) Two-stage assay of IL2 production by NOB-l in response to pILla (0) or b ( q I); 
the effect of recombinant murine ILlcv is shown for comparison (A). All points are means of triplicate determinations. 
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the homobifunctional reagent EGS exactly as in 
[4]. For photoaffinity labelling, cells were in- 
cubated with 12sI-IL1 (9.5 x lo-” M) as described 
above, washed free of unbound ligand and 
suspended in PBS (4 x lO’/ml). SS was added to 
a final concentration of 2.5 mM and the reaction 
was allowed to proceed in total darkness for 
20 min at 0°C before photolysis for 5 min using 
the 366 nm output of a hand-held ultraviolet lamp 
at 10 cm from the samples. After the reaction had 
been quenched by the addition of 2 vols of 10 mM 
Tris-HCl, pH 7.5/l mM EDTA, cells were pelleted 
and prepared for electrophoresis as in [4]. 
Crosslinked complexes were identified in 7.5% 
polyacrylamide gels according to Laemmli [12]. 
Fig.2. Scatchard analysis of equilibrium binding of ‘251- 
pILla to NOB-l and 3T3 cells. Binding assays were 
carried out as described in the text, each point being 
derived from the mean of triplicate determinations from 
which non-specific binding (measured in the presence of 
1 pg/ml unlabelled ILl) has been subtracted. Straight 
lines were fitted to the points by a least-squares method 
(r = 0.984 for NOB-l and 0.959 for 3T3). 3. RESULTS AND DISCUSSION 
cells were washed twice with binding buffer, 
resuspended at 5 x 106/ml, and aliquots (0.3 ml) 
incubated with IL1 samples for 2.5 h at 12°C. 
Bound radioligand was separated from free using 
the phthalate oil method described by Dower et al. 
[lo]. All binding data were analysed by the 
LIGAND program [ 111. 
2.5. Covalent cross-linking and gel electrophoresis 
1251-pILls were crosslinked to intact cells using 
Fig.lA shows that he half-maximal doses of 
each form of pIL1 required to stimulate increased 
glycolysis in confluent 3T3 cells were very similar; 
we chose to assay lactate production since, in our 
hands, 3T3 fibroblasts did not proliferate in 
response to pILl as has been reported using recom- 
UNLABELLED IL-l tnglmll 
Fig.3. Displacement of ‘251-pILl~ by unlabelled ILla and p. 3T3 cells (A) and NOB-l cells (B) were incubated with 
120 pM 1251-ILlcu and increasing concentrations of unlabelled ILla (0) or ILl,& (0). After subtraction of non-specific 
binding the amount of radioactivity bound at each dose was compared to that bound in the presence of tracer alone 
(3306 cpm in A, 3059 cpm in B). Each point is the mean of triplicate determinations. 
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binant human IL1 [5]. In contrast, pILlP was less 
potent, by two orders of magnitude, in stimulating 
IL2 production by NOB-l (fig.lB). The EDso for 
pILlP was 0.7 pM, comparable to recombinant 
murine ILlcu; the EDso for pILl,& was 71 pM. 
These findings prompted us to examine the binding 
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Fig.4. (A) Photoaffinity crosslinking of 1251-pILl~ to intact cells. 10’ NOB-l cells (lanes l-3) and 6 x lo5 3T3 cells 
(lanes 4-6) were incubated at 12°C with 950 pM 1251-ILla either alone (lanes 1,4) or in the presence of 95 nM unlabelled 
pILlcv (lanes 2,5) or ,8 (lanes 3,6). After crosslinking with 2.5 mM SS as described, the cells were solubilized and run 
under reducing conditions on 7.5% SDS-polyacrylamide gels. Autoradiographs of the dried gels are shown together with 
the migration positions of protein markers (8-galactosidase, phosphorylase a, transferrin, bovine serum albumin, IgG, 
ovalbumin). (B) Comparison of crosslinking patterns obtained using i2’I-labelled pILla and /3. Experiments using SS 
were carried out as described above; crosslinking using EGS (0.5 mM) was as described in section 2. Gels were run under 
reducing conditions. 
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of porcine IL1 to murine IL1 receptors. Scatchard 
analysis (fig.2) revealed that, in each cell type, *251- 
pILlcv bound to a single class of receptors. In the 
typical experiments shown we detected 1500 
binding sites on NOB-l (& = 420 pM) and 5900 
sites on 3T3 (& 550 PM). Our finding of a single 
class of receptors confirms previous reports using 
3T3 [5] and EL-4 cells [6]. Despite using an IL1 
preparation of comparable specific activity we 
found no evidence to support the existence of high- 
and low-affinity receptor populations as was 
described for binding of human rIL1 to EL-4-6.1 
[13], the parent line of NOB-l. 
The relative potency of pILl,& in the two assays 
was reflected in its ability to displace 1251-pILla 
(fig.3), thus in the 3T3 binding assay unlabelled 
ILl,& was equipotent with unlabelled ILlmu; in four 
experiments the inhibition constant for displace- 
ment ranged between 104 and 740 pM for ILla 
and 156-175 pM for ILlfl. The respective Ki 
values for NOB-l were 110-340 pM and 
1.1-2.3 nM. These data suggest that murine cells 
of independent lineage are able to discriminate at 
the level of receptor binding, between forms of 
porcine ILl. One implication is that the structure 
of the IL1 receptor must have evolved along 
separate lines in the two cell types resulting in an 
altered capacity to recognise pILlp without altera- 
tion in their ability to bind pILlcu. 
In order to explore the possibility that there 
might be structural differences between the recep- 
tors on the two cell types we investigated the cell 
surface components that could be covalently 
crosslinked to ILl. Other investigators [4-71 have 
used homobifunctional crosslinkers; the success of 
this approach depends upon the close proximity of 
amino side groups in ligand and receptor. We have 
also used a heterobifunctional reagent, SS, in 
which a highly reactive nitrene group is 
photochemically generated, capable of insertion 
into C-C and C-H bonds, resulting in less 
restricted crosslinking. Crosslinking of 1251-pILla 
to NOB-l and 3T3 with SS revealed a single high 
molecular mass complex of 120 kDa (fig.4A), 
which was not formed if the cells were incubated in 
the presence of a IOO-fold excess of unlabelled 
ILla or p, indicating that both ligands became 
associated with a polypeptide of 100 kDa. Similar 
results were obtained when electrophoresis was 
carried out without prior reduction of the samples 
(not shown). Crosslinking of IL10 resulted in the 
formation of a major band at around 97 kDa with 
both SS and EGS (fig.4B); in some cases, both 
bands were visible using the latter reagent, this was 
also the case with ILlcu. The possibility of pro- 
teolytic artefacts was excluded by performing these 
experiments with or without proteinase inhibitors 
(pepstatin A, EDTA, phenylmethylsulfonyl 
fluoride, and N-ethylmaleimide); in each case the 
patterns were the same (not shown). The same pat- 
terns were also observed using SS concentrations 
between 0.025 and 5 mM, therefore it seems 
unlikely that the 120 kDa complex arose through 
crosslinking of two IL1 molecules to a single 
80 kDa component. As far as we can ascertain, the 
crosslinking profiles of NOB-l and 3T3 are iden- 
tical, so whatever the structural difference between 
the two cell types’ receptors, it is not revealed at 
this level. Our finding of a 97 kDa band is in agree- 
ment with previous reports [4,5] of an 80 kDa 
murine ILl-receptor protein, but this study is the 
first to identify a second, larger receptor compo- 
nent. Although crosslinking studies cannot unam- 
biguously define ligand-binding polypeptides, 
three alternative interpretations might be con- 
sidered: firstly, a precursor is differentially pro- 
cessed to two forms of receptor (i.e. 80 and 
100 kDa); secondly, there are in fact two genetical- 
ly distinct types of receptor; and thirdly, the IL1 
receptor comprises two different polypeptide 
chains. Purification of the two components is 
underway in order to distinguish between these 
possibilities. 
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